J.P. Morgan Health Conference - Day 3 Highlights

Day 3 was pretty quiet.  Macro CPI print dominated the tape this morning with the hot number driving some risk off in biotech. 

Health Care Conference (jpmorgan.com)

WSJ published an updated headline that NVS may be backing away from a CYTK deal >$10 billion. 

Cytokinetics Stock Drops After Journal Report That Novartis Deal Might Be Off (wsj.com)

We expect some consolidation into earnings season and expected follow-on offering activity for development stage companies.